PKC-ι Regulates an Oncogenic Positive Feedback Loop Between the MAPK/JNK Signaling Pathway, c-Jun/AP-1 and TNF-α in Breast Cancer
Authors:
- Nuzhat Nowshin OisheeNONuzhat Nowshin Oishee
- Mahfuza MarzanMMMahfuza Marzan
- Abigail Oluwafisayo OlatunjiAOAbigail Oluwafisayo Olatunji
- Khandker Mohammad KhalidKKKhandker Mohammad Khalid
- Abiral Hasib ShouravASAbiral Hasib Shourav
- Radwan Ebna NoorRNRadwan Ebna Noor
- Anna KharitonovaAKAnna Kharitonova
- Aaron Joshua AstalosAAAaron Joshua Astalos
- James W. LeahyJLJames W. Leahy
- Mildred Acevedo-DuncanMAMildred Acevedo-Duncan
Preprint
- 16 June 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Breast cancer is the second most common cancer in the United States and consists of 30% of all new female cancer each year. PKC iota (PKC-ι) is a Bonafide human oncogene and is overexpressed in many types of cancer, including breast cancer. This study explores the role of PKC-ι in regulating the transcription factor Jun proto-oncogene (c-Jun), pro-inflammatory cytokine Tumor Necrosis Factor-alpha (TNF-α), and the Mitogen-Activated Protein Kinase/ Jun N-terminal kinase (MAPK/JNK) pathway, which also exhibits an oncogenic role in breast cancer. ICA-1S, a PKC-ι specific inhibitor, was used to inhibit PKC-ι to observe the subsequent effect in the levels of c-Jun, TNF-α and the MAPK/JNK signaling pathway. To obtain the results, cell proliferation assay, Western blotting, co-immunoprecipitation, small interfering RNA (siRNA), immunofluorescence, flow cytometry, cycloheximide (CHX) chase assay, and reverse transcription quantitative PCR (RT-qPCR) techniques were implemented. ICA-1S significantly inhibited cell proliferation and induced apoptosis in both breast cancer cell lines. Treatment with ICA-1S and siRNA also reduced the expression levels of the MAPK/JNK pathway protein, c-Jun and TNF-α in both cell lines. PKC-ι was also found to be strongly associated with c-Jun, via which it regulated the MAPK/JNK pathway. Additionally, ICA-1S was found to promote the degradation of c-Jun and decrease the mRNA levels of c-Jun. We concluded that PKC-ι plays a crucial role in regulating breast cancer, and inhibition of PKC-ι by ICA-1S reduces breast cancer cell proliferation and induces apoptosis. Therefore, targeting PKC-ι as a potential therapeutic target in breast cancer could be a significant approach in breast cancer research.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- MCF-7 cells lack the expression of Caspase-3International Journal of Biological Macromolecules, 2023
- A simple method for quantitating confocal fluorescent imagesBiochemistry and Biophysics Reports, 2021
- The MAPK pathway across different malignancies: A new perspectiveCancer, 2014
- c-Jun, at the crossroad of the signaling networkProtein & Cell, 2011
- A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastomaThe International Journal of Biochemistry & Cell Biology, 2011
- The overexpression and altered localization of the atypical protein kinase C λ/ι in breast cancer correlates with the pathologic type of these tumorsHuman Pathology, 2008
- c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancerHuman Pathology, 2006
- Atypical PKC-ζ and PKC-ι mediate opposing effects on MCF-7 Na+/K+ATPase activityJournal of Cellular Physiology, 2005
- AP-1 function and regulationCurrent Opinion in Cell Biology, 1997
- The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1Cell, 1988